Distribution of Acute and Chronic Kidney Disease Across Clinical Phenotypes for Sepsis

被引:3
|
作者
Molinari, Luca [1 ,2 ,5 ]
Del Rio-Pertuz, Gaspar [2 ,4 ]
Priyanka, Priyanka [2 ]
Smith, Ali [1 ]
Maggiore, Joseph C. [3 ]
Kennedy, Jason [1 ]
Gomez, Hernando [1 ,2 ]
Seymour, Christopher W. [1 ]
Kellum, John A. [1 ,2 ]
机构
[1] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Ctr Crit Care Nephrol, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA
[4] Univ Minnesota, Div Cardiol, Dept Med, Minneapolis, MN USA
[5] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy
基金
美国国家卫生研究院;
关键词
acute kidney disease; acute kidney injury; biomarkers; chronic kidney disease; endotypes; insulin-like growth factor binding protein 7; phenotypes; sepsis; septic shock; tissue inhibitor of metalloproteinases-2; CRITICALLY-ILL PATIENTS; ALKALINE-PHOSPHATASE; INJURY; RECOVERY; FAILURE; AKI;
D O I
10.1016/j.chest.2024.03.006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Sepsis is the most common cause of acute kidney injury (AKI) in critically ill patients. Four phenotypes (alpha, beta , gamma , delta) for sepsis, which have different outcomes and responses to treatment, were described using routine clinical data in the electronic health record. RESEARCH QUESTION: Do the frequencies of AKI, acute kidney disease (AKD), chronic kidney disease (CKD), and AKI on CKD differ by sepsis phenotype? STUDY DESIGN AND METHODS: This was a secondary analysis of a randomized clinical trial of early resuscitation, including patients with septic shock at 31 sites. After excluding patients with end-stage kidney disease and missing data, we determined frequencies of the following clinical outcomes: AKI (defined fi ned within 24 h as Kidney Disease: Improving Global Outcomes stages 2 or 3 or stage 1 with tissue inhibitor of metalloproteinases-2 x insulin-like growth factor binding protein 7 value of > 2.0), CKD, and AKD (persistence of AKI at any stage on day 7 after enrollment) across four phenotypes. We performed multivariable logistic regression to assess the risk-adjusted association between development of AKI and AKD and phenotype. RESULTS: Among 1,090 eligible patients, 543 patients (50%) had AKI. Across phenotypes, the frequencies of AKI varied, being highest in the delta and beta phenotypes (78% and 71%, respectively) and the lowest in the alpha phenotype (26%; P < .001). AKD occurred most often in the delta phenotype (41%) and least often in the alpha phenotype (8%; P < .001). The highest frequencies of CKD and of AKI on CKD were found in the beta phenotype (53% and 38% respectively; P < .001 for both). In the multivariable logistic regression models (alpha phenotype as reference), delta phenotype showed the strongest association with AKI (OR, 12.33; 95% CI, 7.81-19.47; P < .001) and AKD (OR, 9.18; 95% CI, 5.44-15.51; P < .001). INTERPRETATION: The rates of AKI and AKD differed across clinical sepsis phenotypes and are more common among patients with phenotypes beta and delta. Phenotype beta showed a higher level of underlying CKD that predisposed patients to new AKI. The alpha and gamma phenotypes showed lower frequencies of AKI and less progression to AKD.
引用
收藏
页码:480 / 490
页数:11
相关论文
共 50 条
  • [41] Leptospirosis kidney disease: Evolution from acute to chronic kidney disease
    Chou, Li-Fang
    Yang, Huang-Yu
    Hung, Cheng-Chieh
    Tian, Ya-Chung
    Hsu, Shen-Hsing
    Yang, Chih-Wei
    BIOMEDICAL JOURNAL, 2023, 46 (04)
  • [42] EVALUATING THE CLINICAL PHENOTYPES ASSOCIATED WITH PROGRESSION TO CHRONIC KIDNEY DISEASE USING AN UNSUPERVISED MACHINE LEARNING APPROACH
    Al-Mamun, M.
    Brothers, T.
    Jeun, K. J.
    Ahmed, I
    VALUE IN HEALTH, 2024, 27 (06) : S54 - S54
  • [43] Inflammatory Bowel Disease With Chronic Kidney Disease and Acute Kidney Injury
    Liu, Mengyi
    Zhang, Yanjun
    Ye, Ziliang
    Yang, Sisi
    Zhou, Chun
    He, Panpan
    Zhang, Yuanyuan
    Hou, Fan Fan
    Qin, Xianhui
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2023, 65 (06) : 1103 - 1112
  • [44] Can acute kidney disease progress to chronic kidney disease in children?
    Chisavu, Flavia
    Stroescu, Ramona
    Chisavu, Lazar
    Ruxandra, Steflea
    Gafencu, Mihai
    PEDIATRIC NEPHROLOGY, 2024, 39 (01) : S82 - S83
  • [45] CLINICAL SIGNIFICANCE OF THE INTERVAL CHANGE OF PLASMA NGAL IN PATIENTS WITH ACUTE KIDNEY INJURY AND ACUTE KIDNEY INJURY SUPERIMPOSED ON CHRONIC KIDNEY DISEASE
    Ma, Seong Kwon
    Kim, Ha Yeon
    Bae, Eun Hui
    Kim, Soo Wan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 190 - 190
  • [46] Clinical management of chronic kidney disease
    Methven, Shona
    MacGregor, Mark S.
    CLINICAL MEDICINE, 2009, 9 (03) : 269 - 272
  • [47] Acute Ischemic Stroke and Acute on Chronic Kidney Disease
    Aftab, Raja Ahsan
    Khan, Amer Hayat
    AbdulRaazaq, Hadeer Akram
    Adnan, Azreen Syazril
    JOURNAL OF NEPAL MEDICAL ASSOCIATION, 2016, 54 (02) : 85 - 87
  • [48] Statin use and sepsis in patients with chronic kidney disease - In reply
    Gupta, Rajesh
    Plantinga, Laura C.
    Coresh, Josef
    Powe, Neil R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (03): : 284 - 285
  • [49] Procalcitonin as a Marker of Atrial Fibrillation in Chronic Kidney Disease and Sepsis
    Bontekoe, Jack
    Bansal, Vinod
    Lee, Justin
    Syed, Mushabbar
    Hoppensteadt, Debra
    Maia, Paula
    Walborn, Amanda
    Liles, Jeffrey
    Vasaiwala, Smit
    Statz, Stephen
    Fareed, Jawed
    CIRCULATION, 2018, 138
  • [50] Statin use and hospitalization for sepsis in patients with chronic kidney disease
    Gupta, Rajesh
    Plantinga, Laura C.
    Fink, Nancy E.
    Melamed, Michal L.
    Coresh, Josef
    Fox, Caroline S.
    Levin, Nathan W.
    Powe, Neil R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (13): : 1455 - 1464